Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Digitale Medien
    Digitale Medien
    Oxford, UK : Blackwell Publishing Ltd
    Annals of the New York Academy of Sciences 770 (1995), S. 0 
    ISSN: 1749-6632
    Quelle: Blackwell Publishing Journal Backfiles 1879-2005
    Thema: Allgemeine Naturwissenschaft
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1569-8041
    Schlagwort(e): autologous hematopoietic stem-cell transplantation ; chronic lymphocytic leukemia ; relapse rate ; small lymphocytic lymphoma
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Background: High-dose therapy followed by autologous stem-cell transplantation (autoSCT) induces complete remissions in the majority of patients with advanced B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma (B-CLL). However, the long-term utility of this therapy for B-CLL is unknown. Patients and methods: Sixteen previously treated patients with B-CLL were transplanted using autologous blood (n = 13) or bone marrow (n = 3). The median age of the patients was 49 years (range 44–60 years), and the median number of prior chemotherapy regimens was two. Patients were eligible for transplantation if they had chemosensitive disease and no morphologic evidence of malignant cells in the graft. Preparative regimens included cyclophosphamide and total-body-irradiation, with or without cytarabine, or BEAC. Results: All patients engrafted and achieved a complete remission posttransplant. Ten patients were alive at a median of 41 months (range 22–125 months), and five were disease-free. Eight patients have relapsed and six have died (three from progressive malignancy). The projected three-year overall survival, failure-free survival and relapse rates were 68%, 37%, and 56%, respectively. Conclusions: AutoSCT for advanced B-CLL is associated with a high relapse rate. Whether this therapy can prolong life or produce cures is uncertain.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Digitale Medien
    Digitale Medien
    Springer
    Annals of oncology 9 (1998), S. 23-30 
    ISSN: 1569-8041
    Schlagwort(e): blood cell transplant ; marrow transplant
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Stem cell transplantation has played a role in the management of diffuse large-cell lymphoma for decades. The optimal source of the stem cells and the proper composition of the cellular graft product has not been defined. The field is changing rapidly and the future is likely to hold improvements and requirements that will further benefit the patient!
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    ISSN: 1573-7217
    Schlagwort(e): stem cells ; progenitor cells ; long-term bone marrow cultures ; occult tumor
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract The maintenance of hematopoietic progenitor cells as assayedin the mixed colony (CFU-GEMM) assay in humanlong-term bone marrow cultures was compared between normalallogeneic marrow transplantation donor collections and those fromcandidates for high-dose therapy and autologous bone marrowtransplantation (ABMT). To be eligible for ABMT, patientswere required to have a histologically normal appearingbone marrow and therefore any tumor contamination wasat minimal levels and detectable only after evaluationof the cultured harvests. Marrow from 15 normaldonors, 36 patients with breast cancer, and 30patients with Hodgkin's disease was evaluated. The numberof mononuclear cells placed in culture was standardized.In all groups, significantly more progenitor cells wererecovered at 4–6 weeks of culture than at12–14 weeks. At 4–6 and 12–14 weeks, therewere no significant differences in the number ofprogenitor cells recovered from the cultures of normaldonors and tumor negative cultures of breast canceror Hodgkin's disease patients. However, following 4–6 and12–14 weeks of culture, progenitor cell numbers ofcultures which contained breast cancer cells were significantlyhigher than the pooled values for cultures fromthe concurrent normal controls, and those from breastcancer and Hodgkin's disease patients with tumor negativecultures. These results suggest that minimal breast cancercell contamination of the bone marrow can influencethe production of marrow progenitor cells. Exposure toprior chemotherapy or radiation therapy does not appearto be the cause of this effect. Themost likely mechanism is the local production ofcytokines by the tumor cells, although a processinvolving direct adhesive contact of the tumor cellswith hematopoietic cells, which is sometimes observed insemisolid cultures, cannot be excluded.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...